-+ 0.00%
-+ 0.00%
-+ 0.00%

4D MOLECULAR THERAPEUTICS INC - 4FRONT-2 PHASE 3 TRIAL INITIATED AHEAD OF SCHEDULE

Reuters·07/02/2025 20:05:30

Please log in to view news